Healwell AI Yönetim

Yönetim kriter kontrolleri 2/4

Healwell AI's CEO'su Alex Dobranowski, Sep2020 tarihinde atandı, in görev süresi 4.08 yıldır. in toplam yıllık tazminatı CA$ 603.74K olup, şirket hissesi ve opsiyonları dahil olmak üzere 58% maaş ve 42% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.34% ine doğrudan sahiptir ve bu hisseler € 2.22M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1 yıl ve 3.8 yıldır.

Anahtar bilgiler

Alex Dobranowski

İcra Kurulu Başkanı

CA$603.7k

Toplam tazminat

CEO maaş yüzdesi	58.0%
CEO görev süresi	4.1yrs
CEO sahipliği	1.2%
Yönetim ortalama görev süresi	less than a year
Yönetim Kurulu ortalama görev süresi	3.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Alex Dobranowski'un ücretlendirmesi Healwell AI'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-CA$18m
Mar 31 2024	n/a	n/a	-CA$31m
Dec 31 2023	CA$604k	CA$350k	-CA$32m
Sep 30 2023	n/a	n/a	-CA$28m
Jun 30 2023	n/a	n/a	-CA$29m
Mar 31 2023	n/a	n/a	-CA$21m
Dec 31 2022	CA$350k	CA$350k	-CA$18m
Sep 30 2022	n/a	n/a	-CA$21m
Jun 30 2022	n/a	n/a	-CA$17m
Mar 31 2022	n/a	n/a	-CA$17m
Dec 31 2021	CA$1m	CA$350k	-CA$16m
Sep 30 2021	n/a	n/a	-CA$13m
Jun 30 2021	n/a	n/a	-CA$6m
Mar 31 2021	n/a	n/a	-CA$3m
Dec 31 2020	CA$29k	CA$29k	-CA$1m

Tazminat ve Piyasa: Alex 'nin toplam tazminatı ($USD 447.72K ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 811.38K ).

Tazminat ve Kazançlar: Alex şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Alex Dobranowski

4.1yrs

Görev süresi

CA$603,735

Tazminat

Dr. Alexander Julian Dobranowski, also known as Alex, is the Founder and Managing Director of Healwell Al Inc. (formerly known as Healwell AI Inc. (formerly known as MCI Onehealth Technologies Inc.)) and i...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Alexander Dobranowski	Founder	4.1yrs	CA$603.74k	1.22% € 1.8m
Madeline Walker	President of MCI Medical	2.6yrs	CA$627.87k	Veri yok
Donald Watts	President of Khure Health	no data	CA$481.00k	Veri yok
Anthony Lam	Chief Financial Officer	less than a year	Veri yok	Veri yok
Paulo Gomes	Co-Chief Operating Officer	no data	Veri yok	Veri yok
Adam Hutton	Co-Chief Operating Officer	no data	Veri yok	Veri yok
Nolan Reeds	Vice President of Marketing & Communications	no data	Veri yok	Veri yok
Blake Corbet	Senior Vice President of Corporate Development	less than a year	Veri yok	0.079% € 116.7k
Mark Findlay	Senior Vice President of Sales & Marketing for Canada	less than a year	Veri yok	Veri yok

1.0yrs

Ortalama Görev Süresi

Deneyimli Yönetim: 6H90 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Alexander Dobranowski	Founder	4.8yrs	CA$603.74k	1.22% € 1.8m
Hamed Shahbazi	Chairman of the Board	less than a year	Veri yok	Veri yok
J. R. Ward	Independent Lead Director	3.8yrs	CA$61.00k	0.72% € 1.1m
Bashar Al-Rehany	Independent Director	3.8yrs	CA$125.00k	0.012% € 17.9k
Erik Danudjaja	Independent Director	less than a year	Veri yok	0.011% € 16.7k

3.8yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 6H90 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.8 yıldır).

Healwell AI Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Healwell AI Inc. Announces Chief Financial Officer Changes

Healwell AI Inc., Annual General Meeting, Jun 25, 2024

Healwell AI Inc., Annual General Meeting, Jun 12, 2024

Healwell AI Inc. Announces Executive Changes

Healwell Ai Inc. Appoints Mark Findlay as Senior Vice President of Sales and Marketing for Canada

Less than half of directors are independent

Recent updates

New minor risk - Financial position

Second quarter 2024 earnings released

Healwell AI Inc. to Report Q2, 2024 Results on Aug 12, 2024

Healwell AI Inc. (TSX:AIDX) acquired 20% stake in Mci Polyclinic Group Inc.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of VeroSource Solutions Inc.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire VeroSource Solutions Inc. for CAD 24.5 million on June 11, 2024.

Healwell AI Inc. Announces Chief Financial Officer Changes

Healwell AI Inc. announced that it has received CAD 20.00025 million in funding

First quarter 2024 earnings released: CA$0.06 loss per share (vs CA$0.14 loss in 1Q 2023)

Healwell AI Inc. to Report Q1, 2024 Results on May 14, 2024

Healwell AI Inc. announced that it expects to receive CAD 16.000065 million in funding

Healwell AI Inc., Annual General Meeting, Jun 25, 2024

Healwell AI Inc., Annual General Meeting, Jun 12, 2024

Full year 2023 earnings released: CA$0.56 loss per share (vs CA$0.42 loss in FY 2022)

Healwell AI Inc. to Report Q4, 2023 Results on Mar 28, 2024

Healwell AI Inc. Announces Executive Changes

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

New major risk - Shareholder dilution

Healwell AI Inc. has completed a Composite Units Offering.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of an unknown majority stake in Pentavere Research Group Inc. Christopher Pettengell, Aviva Pratzer, Mark Harris, Steven Aviv, Hilton Silberg, AAron Leibtag and others.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire an unknown stake in Pentavere Research Group Inc. for CAD 5.9 million.

Third quarter 2023 earnings released: CA$0.14 loss per share (vs CA$0.18 loss in 3Q 2022)

Healwell Ai Inc. Appoints Mark Findlay as Senior Vice President of Sales and Marketing for Canada

Healwell AI Inc. to Report Q3, 2023 Results on Nov 15, 2023

Healwell AI Inc. announced that it has received CAD 3.00024 million in funding

Less than half of directors are independent

Healwell Al Inc. Announces Board and Executive Changes

High number of new and inexperienced directors

MCI Onehealth Technologies Inc. Announces Sven Grail and George Christodoulou, the Former Co-Chairs, Did Not Stand for Re-Election

New major risk - Negative shareholders equity

Second quarter 2023 earnings released: CA$0.21 loss per share (vs CA$0.084 loss in 2Q 2022)

MCI Onehealth Technologies Inc., Annual General Meeting, Sep 21, 2023

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million.

MCI Onehealth Technologies Inc. announced that it has received CAD 1.5 million in funding

First quarter 2023 earnings released: CA$0.15 loss per share (vs CA$0.086 loss in 1Q 2022)

MCI Onehealth Technologies Inc. Announces Changes to Management Team Structure

High number of new and inexperienced directors

MCI Onehealth Technologies Inc. to Report Q3, 2022 Results on Nov 14, 2022

MCI Onehealth Technologies Inc. Expands Data Insights Offering with Innovative AI-driven Continuing Medical Education

Second quarter 2022 earnings released: CA$0.084 loss per share (vs CA$0.058 loss in 2Q 2021)

MCI Onehealth Technologies Inc. to Report Q2, 2022 Results on Aug 15, 2022

MCI Onehealth Technologies Inc. Provides Revenue Guidance for the Year 2022

First quarter 2022 earnings released: CA$0.084 loss per share (vs CA$0.054 loss in 1Q 2021)

MCI Onehealth Technologies Inc. to Report Q1, 2022 Results on May 16, 2022

Less than half of directors are independent

MCI Onehealth Technologies Inc., Annual General Meeting, Jun 17, 2022

Full year 2021 earnings released: CA$0.33 loss per share (vs CA$0.027 loss in FY 2020)

MCI Onehealth Technologies Inc. Provides Revenue Guidance for Fiscal 2022

MCI Onehealth Appoints Jennifer Foster as Chief Operating Officer with Mandate to Support Expansion of Tech and Data Offerings

Third quarter 2021 earnings released: CA$0.11 loss per share

Co-Founder & Co-Executive Chair recently bought €58k worth of stock

Second quarter 2021 earnings released

MCI Onehealth Technologies Inc. (TSX:DRDR) acquired a 9% stake in ReGen Scientific Inc.

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş